BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10482971)

  • 21. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
    Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study.
    Larsen CT; Dahlin J; Blackburn H; Scharling H; Appleyard M; Sigurd B; Schnohr P
    Eur Heart J; 2002 Feb; 23(4):315-24. PubMed ID: 11812068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac arrhythmias and left ventricular hypertrophy in dipper and nondipper patients with essential hypertension.
    Ijiri H; Kohno I; Yin D; Iwasaki H; Takusagawa M; Iida T; Osada M; Umetani K; Ishihara T; Sawanobori T; Ishii H; Komori S; Tamura K
    Jpn Circ J; 2000 Jul; 64(7):499-504. PubMed ID: 10929777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential impact of left ventricular mass and relative wall thickness on cardiovascular prognosis in diabetic and nondiabetic hypertensive subjects.
    Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Pickering TG; Schwartz JE; Homma S; Shimada K; Kario K
    Am Heart J; 2007 Jul; 154(1):79.e9-15. PubMed ID: 17584557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of ventricular arrhythmias in systemic hypertension.
    Galinier M; Balanescu S; Fourcade J; Dorobantu M; Boveda S; Massabuau P; Cabrol P; Dongay B; Fauvel JM; Bounhoure JP
    J Hypertens; 1997 Dec; 15(12 Pt 2):1779-83. PubMed ID: 9488239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
    Wang HB; Shi Q; Zhang C
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the incidences of left ventricular hypertrophy, left ventricular diastolic dysfunction, and arrhythmia between patients with dipper and non-dipper hypertension].
    Ersoylu ZD; Tuğcu A; Yildirimtürk O; Aytekin V; Aytekin S
    Turk Kardiyol Dern Ars; 2008 Jul; 36(5):310-7. PubMed ID: 18984982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).
    Erküner Ö; Dudink EAMP; Nieuwlaat R; Rienstra M; Van Gelder IC; Camm AJ; Capucci A; Breithardt G; LeHeuzey JY; Lip GYH; Crijns HJGM; Luermans JGLM
    Am J Cardiol; 2018 Aug; 122(4):578-583. PubMed ID: 29958714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What Is the Effect of Metabolic Syndrome without Hypertension on Left Ventricular Hypertrophy?
    Al-Daydamony MM; El-Tahlawi M
    Echocardiography; 2016 Sep; 33(9):1284-9. PubMed ID: 27109543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevalence of supraventricular arrhythmias with regard to the type and degree of left ventricular hypertrophy in patients with hypertensive heart disease.
    Kunisek J; Zaputovic L; Butorac MZ; Kunisek L; Lukin-Eskinja K; Karlavaris R; Bruketa-Markic I
    Wien Klin Wochenschr; 2008; 120(5-6):171-7. PubMed ID: 18365157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
    Gerdts E; Zabalgoitia M; Björnstad H; Svendsen TL; Devereux RB
    Am J Cardiol; 2001 Apr; 87(8):980-3; A4. PubMed ID: 11305990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac arrhythmias and left ventricular hypertrophy in systemic hypertension.
    Sultana R; Sultana N; Rashid A; Rasheed SZ; Ahmed M; Ishaq M; Samad A
    J Ayub Med Coll Abbottabad; 2010; 22(4):155-8. PubMed ID: 22455286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Hornestam B; Lehto M; Slotwiner DJ; Gerdts E; Olsen MH; Aurup P; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Rokkedal J; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):705-11. PubMed ID: 15734614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Level of Physical Activity, Left Ventricular Mass, Hypertension, and Prognosis.
    Joseph G; Marott JL; Biering-Sørensen T; Johansen MN; Saevereid HA; Nielsen G; Schnohr P; Prescott E; Søgaard P; Mogelvang R
    Hypertension; 2020 Mar; 75(3):693-701. PubMed ID: 31884852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study.
    Kahn S; Frishman WH; Weissman S; Ooi WL; Aronson M
    J Am Geriatr Soc; 1996 May; 44(5):524-9. PubMed ID: 8617900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
    Gerdts E; Wachtell K; Omvik P; Otterstad JE; Oikarinen L; Boman K; Dahlöf B; Devereux RB
    Hypertension; 2007 Feb; 49(2):311-6. PubMed ID: 17178978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF; Cardoso CR; Fiszman R; Muxfeldt ES
    Am Heart J; 2010 May; 159(5):833-40. PubMed ID: 20435193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.